SCI Pharmtech Inc (4119) — Cash Flow-to-Debt Ratio
SCI Pharmtech Inc (4119) has a Cash Flow-to-Debt Ratio of 0.02x as of March 2026, meaning its operating cash flow of NT$36.89 Million could theoretically repay 0% of its total liabilities (NT$1.54 Billion) in one year. Explore 4119 long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
SCI Pharmtech Inc Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for SCI Pharmtech Inc across 23 annual periods. Also explore SCI Pharmtech Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for SCI Pharmtech Inc (2002–2025)
Year-by-year debt coverage analysis for SCI Pharmtech Inc. For market capitalisation and broader financial context, see 4119 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | NT$220.32 Million | NT$1.49 Billion | ▼ -70.4% |
| 2024 | 0.50x | NT$860.52 Million | NT$1.72 Billion | ▲ +268.0% |
| 2023 | 0.14x | NT$215.77 Million | NT$1.59 Billion | ▼ -39.1% |
| 2022 | 0.22x | NT$296.56 Million | NT$1.33 Billion | ▼ -30.9% |
| 2021 | 0.32x | NT$280.28 Million | NT$869.26 Million | ▼ -58.6% |
| 2020 | 0.78x | NT$971.53 Million | NT$1.25 Billion | ▼ -40.3% |
| 2019 | 1.30x | NT$791.60 Million | NT$606.84 Million | ▲ +57.2% |
| 2018 | 0.83x | NT$480.18 Million | NT$578.85 Million | ▲ +7.8% |
| 2017 | 0.77x | NT$281.65 Million | NT$365.88 Million | ▼ -26.5% |
| 2016 | 1.05x | NT$502.11 Million | NT$479.43 Million | ▲ +9.7% |
| 2015 | 0.95x | NT$663.24 Million | NT$695.02 Million | ▲ +164.6% |
| 2014 | 0.36x | NT$358.77 Million | NT$994.64 Million | ▲ +48.9% |
| 2013 | 0.24x | NT$238.57 Million | NT$984.62 Million | ▼ -79.8% |
| 2012 | 1.20x | NT$385.57 Million | NT$321.12 Million | ▲ +85.4% |
| 2011 | 0.65x | NT$249.55 Million | NT$385.26 Million | ▲ +10.5% |
| 2010 | 0.59x | NT$218.96 Million | NT$373.37 Million | ▼ -60.3% |
| 2009 | 1.48x | NT$316.96 Million | NT$214.32 Million | ▲ +14.6% |
| 2008 | 1.29x | NT$245.29 Million | NT$190.16 Million | ▲ +36.1% |
| 2007 | 0.95x | NT$167.53 Million | NT$176.74 Million | ▼ -31.6% |
| 2006 | 1.39x | NT$131.62 Million | NT$94.94 Million | ▲ +133.5% |
| 2004 | 0.59x | NT$76.61 Million | NT$129.03 Million | ▼ -70.4% |
| 2003 | 2.01x | NT$206.86 Million | NT$102.99 Million | ▲ +383.3% |
| 2002 | 0.42x | NT$107.12 Million | NT$257.76 Million | — |